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Summary.-Mature cartilage may be expected to contain populations of hypoxic
cells as a result of the tissues lack of direct vascularization and structure; it may
therefore be at risk from possible radiosensitization.
The hypoxic-cell radiosensitizing drug misonidazole Ro-07-0582 (MISO) was
administered i.v. to mature New Zealand White rabbits at a dose of 100 mg/kg, and
the resulting drug concentrations in both blood and ear-cartilage samples measured
by HPLC. Samples were taken at regular intervals up to 4 h after administration of
MISO.
Blood concentrations of MISO rose rapidly to 240 jig/ml within 5 min of admini-
stration, before falling steadily, with a tl/2 of 45 min. Cartilage levels reached a peak
of70%o of the blood levels '30 min after administration. The levels of MISO then fell,
with a tl/2 of 44 min.
THE INVESTIGATION of hypoxic-cell
sensitizers for use in the radiotherapy of
tumours must include an examination of
normal tissues which would be expected
to contain hypoxic cells. One such tissue
is mature structural cartilage.
This tissue has no direct vasculariza-
tion; the chondrocytes receive 02 and
metabolites by diffusion through the intra-
cellular matrix, from capillaries which
pass around, and occasionally penetrate
the matrix.
Gray & Scott (1964) calculated that the
02 tension of hyaline cartilage, on the
basis of its radiosensitivity, is - 13 kPa.
Silver (1975) has found that the oxygen
tension in the centre of blocks of articular
cartilage growing in rabbit-ear chambers
is 07-1.0 kPa. This value is for small,
immature, actively growing pieces of
cartilage, and it is probable that 02
tensions are much lower where diffusion
distances are greater as in some adult
human cartilages.
Evidence that cartilage may be at
risk was given by Churchill-Davidson
et al. (1957) in a study which showed that
some patients undergoing hyperbaric
oxygen radiotherapy for head and neck
tumours developed late cartilage necrosis.
In this study, rabbit-ear cartilage has
been used to determine whether misoni-
dazole (Ro-07-0582 MISO) reaches the
tissue and achieves a sufficiently high
concentration to cause sensitization during
subsequent irradiation.
MATERIALS AND METHODS
Throughout the series of experiments the
cartilage was obtained from the ears offemale
Newsr Zealand White rabbits, mean w%eight
3-96 kg + 0-96 (s.e.)
The animals w%Nere anaesthetized with a
single dose of sodium pentabarbitone (15 mg/
kg) (Sagatal, May and Baker). The anaesthetic
was given i.v. by means of a cannula located
in the marginal ear vein. The cannula also
provide a convenient route for the adminis-
tration of MISO, kindly donated by Dr C. E.
Smithen, Roche Products Ltd. The drug wasMISONIDAZOLE IN STRUCTURAL CARTILAGE
injected as a bolus injection in sterile isotonic
saline at a dose of 100 mg/kg. The site of
administration was avoided by collecting the
samples from the opposite ear.
Blood samples were taken from the mar-
ginal ear vein by venepuncture and, by
controlling the flow of blood with an artery
clamp, several samples could be obtained
from the same site. Sequential blood samples
were collected in heparinized tubes, about
2 ml being taken for analysis.
Cartilage samples were taken from the
ear by means ofa punch. The layers ofepithe-
lium and connective tissue were stripped off
with a scalpel and forceps. 250 mg ofcartilage
were required for each analysis.
Using these techniques, serial blood sam-
ples could be taken throughout the experi-
ment, but cartilage for only one time point
was obtained per rabbit. All samples were
frozen in liquid N2 within 5 min of removal
from the animal.
The levels of MISO in the samples were
determined by HPLC using the following
technique (after Workman et al., 1978).
The cartilage was finely chopped with scissors
before being homogenized in distilled water
using an Ultra Turrax homogenizer. Aliquots
of known volume of homogenate or blood
were extracted in 9 volumes of HPLC-grade
methanol containing 10 Hg of Ro-07-0741
per sample as an internal standard. The
samples were mixed for 30 min in a rotary
mixer before being centrifuged for 10 min
at 2000 rev/min. The supernatant was re-
moved and evaporated to dryness at 45°C
under a stream of dry N2. The residue was
then resuspended in 50 /A methanol from
which 10 td aliquots were applied to the
column, (250 mm long x 4-6 mm in diameter,
Hypersil ODS 5 am). MISO concentrations
were estimated from peak heights and
expressed in ,tg/g tissue or pg/ml blood.
RESULTS
The MISO concentrations found in
both the blood and cartilage samples are
shown in the Figure. Each point on the
curves represents the pooled data from
4-9 animals.
The mean levels in blood were found
to be around 240 tg/ml within 5 min of
administration of MISO, and fell steadily
throughout the observation period. An
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FIGuRE.-Mean misonidazole concentrations
( s.e.) in rabbit blood (-a-) and cartilage
-- ) after administration of 100 mg/kg
i.v. misonidazole
exponential curve fitted to the data by
the method of weighted least squares
gives a t1/2 of 45 0 min + 0-36 (s.e.) in
blood at this dose. The peak concentration
of MISO in cartilage occurred at about
30 min after administration. The levels
declined in a similar fashion to that seen
in blood, with a t1/2 of 44-5 + 0 5 min,
again from an exponential curve fitted
to the data.
The metabolite desmethylmisonidazole
could not be detected in many ofthe sam-
ples and where present was never in
concentrations greater than 4 jtg/ml in
blood or 1 5 pkg/g in cartilage.
DISCUSSION
The results show that MISO can be
detected in ,ug quantities in rabbit blood
and mature cartilage tissues. The t1/2 for
blood of 45 min is of the same order as
that seen normally quoted for small
laboratory animals: 1 0-1 5 h for WHT
mice (Flockhart, 1978), 0-63 h for BALB/c
mice (Workman, 1980). A longer t112 of
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3 h has been quoted by Pedersen et al.
(1979) in C57BL mice, but this followed
a dose of 1 mg/g MISO.
These values for the t1/2 of MISO in
blood for rabbits can also be related to
the values given for larger animals re-
ceiving similar i.v. doses: 3-96 h for dogs
(White et al., 1979) and 3-0-3-66 h for
rhesus monkeys (Ganji et al., 1981).
The situation in man, where the t1/2
in plasma is around 12 h (Gray et al.,
1976; Dische et al., 1977; Wiltshire et al.,
1978), allows tumour drug concentrations
to approach those found in plasma. Tum-
our plasma ratios of 45-77% have been
quoted, 4- h after MISO administration,
in brain tumours by Urtasun et al. (1977)
and more recently Ash et al. (1979) found
ratios of 25-100% in mixed breast, gyn-
aecological and urological tumours.
The pattern of MISO kinetics normally
quoted for small laboratory animals
shows that the short t1/2 in plasma results
in a low tumour drug dose, levels ofMISO
rarely exceeding 50% ofthe corresponding
plasma concentrations (Stratford & Adams
1978; McNally et al., 1978a; Dische
et al., 1977; Denekamp & Fowler, 1978).
However, Brown & Workman (1980)
have shown tumour/plasma ratios ap-
proaching 1 for a dose of 1 0mg/g MISO
given i.p. in BALB/c mice, suggesting
that in certain cases tumour levels may
be independent of its plasma half-life.
The cartilage/plasma ratios of 0 7 seen
in this study appear to be in agreement
with these findings.
The pharmacokinetics of MISO in
cartilage closely resemble the pattern
found in blood, with a t1/2 of 44 min
following an initial lag phase. This simi-
larity is unexpected in a largely avascular
tissue like cartilage. The penetration and
removal of MISO from the tissue are
faster than would be predicted from the
diffusion coefficients normally associated
with cartilage. Aerobic metabolism is
also much lower than that found in other
tissues, 02 utilization being 2-5% of
that found elsewhere (Bywaters, 1937).
However, high concentrations of lactic
dehydrogenase in a form consistent with
a predominantly anaerobic metabolism
have been found by Tushan et al. (1969).
This may lead to a reductive rather than
oxidative breakdown of MISO which may
in part account for the very low levels of
the desmethyl derivative, though this
would not explain the similar lack of
metabolite in the blood.
The doses ofMISO used in these experi-
ments have been shown previously to
sensitize tumours and normal tissue to
the effects of radiation with enhancement
ratios around 1 3-1 5 (Sheldon & Hill,
1977; Denekamp et al., 1974). McNally
et al. (1978b) found that tumour levels
of MISO around 150 ,g/g, similar to
those in cartilage in these experiments,
produce an SER of 1-6-1*8. It would be
reasonable to assume that if the hypoxic
cells received the same dose of MISO as
the tissue as a whole they would be at
risk from irradiation during the peak
drug concentrations.
Radiobiological studies to determine
the effects of MISO in conjunction with
electron irradiation of rabbit-ear cartilage
are at present being carried out.
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